Compile Data Set for Download or QSAR
maximum 50k data
Found 133 Enz. Inhib. hit(s) with all data for entry = 1968
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348745(US9790235, Number I-1)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348746(US9790235, Number I-2)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348747(US9790235, Number I-3)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348748(US9790235, Number I-4)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348750(US9790235, Number I-5)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348751(US9790235, Number I-6)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348753(US9790235, Number I-7)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348754(US9790235, Number I-8)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348755(US9790235, Number I-9)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348757(US9790235, Number I-10)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348759(US9790235, Number I-11)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348762(US9790235, Number I-14)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348763(US9790235, Number I-15)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348765(US9790235, Number I-16)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348766(US9790235, Number I-17)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348767(US9790235, Number I-18)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348768(US9790235, Number I-19)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348769(US9790235, Number I-20)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348770(US9790235, Number I-21)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348771(US9790235, Number I-22)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348772(US9790235, Number I-23)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348774(US9790235, Number I-25)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348775(US9790235, Number I-26)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348776(US9790235, Number I-27)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348777(US9790235, Number I-28)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348778(US9790235, Number I-29)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348779(US9790235, Number I-30)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348781(US9790235, Number I-32)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348786(US9790235, Number I-37)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348787(US9790235, Number I-38)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348788(US9790235, Number I-39)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348789(US9790235, Number I-40)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348790(US9790235, Number I-41)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348791(US9790235, Number I-42)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348792(US9790235, Number I-43)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348793(US9790235, Number I-44)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348794(US9790235, Number I-45)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348795(US9790235, Number I-46)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348796(US9790235, Number I-47)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348797(US9790235, Number I-48)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348798(US9790235, Number I-49)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348799(US9790235, Number I-50)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348800(US9790235, Number I-51)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348802(US9790235, Number I-53)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348803(US9790235, Number I-54)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348805(US9790235, Number I-56)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348806(US9790235, Number I-57)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348807(US9790235, Number I-58)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348808(US9790235, Number I-59)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM348809(US9790235, Number I-60)
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 133 total ) | Next | Last >>
Jump to: